Stylus Medicine

Drug Discovery · Cambridge, MA · Founded 2022 · Privately Held (backing)

Developer of in vivo genetic medicines designed to enable precise insertion of therapeutic genetic material within the human genome. Stylus Medicine is based in Cambridge, MA and was founded in 2022. It was valued at $114 million at its early-stage round in May 2025, the last priced event on record. It has raised $93 million across 1 recorded round; the latest was an $85 million Series A in May 2025.

PMV mark · valuation
$114.0M
Oct 2026
Priced at
its early-stage round
May 2025
Total raised
$93.0M
Last round
Early Stage VC (Series A)
May 2025
What is Stylus Medicine worth?
$114.0MPrivateMarketView mark · Oct 2026

Valued at $114.0M at its early-stage round, May 2025. Nothing has traded since.

Free account
More of Stylus Medicine with a free account
  • ·The complete investor list: 12 names
  • ·Watch Stylus Medicine: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Stylus Medicine funding history

1 rounds
DateRoundRaisedPost-money
May 2025Early Stage VC (Series A)$85.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Stylus Medicine valuation

Stylus Medicine was valued at $114 million at its early-stage round in May 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Stylus Medicine raised?

Stylus Medicine has raised $93 million across 1 recorded round since 2025. The largest was an $85 million Series A in May 2025.

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Arsenal Medical ($124 million), Nocion Therapeutics ($112 million) and Kernalbio ($111 million).

How Stylus Medicine's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Stylus Medicine, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Stylus Medicine

What is Stylus Medicine worth?
Stylus Medicine is valued at $114.0M as of Oct 2026. Valued at $114.0M at its early-stage round, May 2025. Nothing has traded since.
How much has Stylus Medicine raised?
Stylus Medicine has raised $93.0M in total funding across 1 recorded rounds.
When did Stylus Medicine last raise?
Stylus Medicine last raised in May 2025 (Early Stage VC (Series A)), raising $85.0M.